Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease

I Cortese, DS Reich, A Nath - Nature Reviews Neurology, 2021 - nature.com
Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused
by JC virus (JCV), a polyomavirus that commonly establishes persistent, asymptomatic …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Maraviroc: a review of its use in HIV infection and beyond

SM Woollard, GD Kanmogne - Drug design, development and …, 2015 - Taylor & Francis
The human immunodeficiency virus-1 (HIV-1) enters target cells by binding its envelope
glycoprotein gp120 to the CD4 receptor and/or coreceptors such as CC chemokine receptor …

Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

D Pavlovic, AC Patera, F Nyberg… - Therapeutic …, 2015 - journals.sagepub.com
Progressive multifocal leukoencephalopathy (PML) is a rare but debilitating and frequently
fatal viral disease of the central nervous system, primarily affecting individuals with …

Immune reconstitution inflammatory syndrome in HIV-infected patients

NF Walker, J Scriven, G Meintjes… - HIV/AIDS-Research and …, 2015 - Taylor & Francis
Access to antiretroviral therapy (ART) is improving worldwide. Immune reconstitution
inflammatory syndrome (IRIS) is a common complication of ART initiation. In this review, we …

Innate and adaptive immune responses in the CNS

A Waisman, RS Liblau, B Becher - The Lancet Neurology, 2015 - thelancet.com
Almost every disorder of the CNS is said to have an inflammatory component, but the
precise nature of inflammation in the CNS is often imprecisely defined, and the role of CNS …

The use of natalizumab for multiple sclerosis

R Brandstadter, I Katz Sand - Neuropsychiatric disease and …, 2017 - Taylor & Francis
Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent
leukocyte trafficking into the central nervous system. It is US Food and Drug Administration …

Progressive multifocal leukoencephalopathy: current insights

M Kartau, JOT Sipilä, E Auvinen… - Degenerative …, 2019 - Taylor & Francis
Cases of PML should be evaluated according to predisposing factors, as these subgroups
differ by incidence rate, clinical course, and prognosis. The three most significant groups at …

CCR5 blockade for neuroinflammatory diseases—beyond control of HIV

G Martin-Blondel, D Brassat, J Bauer… - Nature Reviews …, 2016 - nature.com
Chemokine receptors have been implicated in a wide range of CNS inflammatory diseases
and have important roles in the recruitment and positioning of immune cells within tissues …